186 related articles for article (PubMed ID: 29637921)
1. Immunohistochemical staining of cytokeratin 20 and cytokeratin 7 in colorectal carcinomas: Four different immunostaining profiles.
Al-Maghrabi J; Emam E; Gomaa W
Saudi J Gastroenterol; 2018; 24(2):129-134. PubMed ID: 29637921
[TBL] [Abstract][Full Text] [Related]
2. Aberrant cytokeratin expression as a possible prognostic predictor in poorly differentiated colorectal carcinoma.
Yamagishi H; Imai Y; Okamura T; Fukuda K; Ono Y; Ban S; Inoue T; Ueda Y
J Gastroenterol Hepatol; 2013 Dec; 28(12):1815-22. PubMed ID: 23808938
[TBL] [Abstract][Full Text] [Related]
3. An immunohistochemical study of primary signet-ring cell carcinoma of the stomach and colorectum: I. Cytokeratin profile in 42 cases.
Terada T
Int J Clin Exp Pathol; 2013; 6(4):703-10. PubMed ID: 23573317
[TBL] [Abstract][Full Text] [Related]
4. CK7, CK20, CDX2 and MUC2 Immunohistochemical staining used to distinguish metastatic colorectal carcinoma involving ovary from primary ovarian mucinous adenocarcinoma.
Shin JH; Bae JH; Lee A; Jung CK; Yim HW; Park JS; Lee KY
Jpn J Clin Oncol; 2010 Mar; 40(3):208-13. PubMed ID: 19926591
[TBL] [Abstract][Full Text] [Related]
5. Cytokeratin 7 and cytokeratin 20 expression in cancer: A tissue microarray study on 15,424 cancers.
Dum D; Menz A; Völkel C; De Wispelaere N; Hinsch A; Gorbokon N; Lennartz M; Luebke AM; Hube-Magg C; Kluth M; Fraune C; Möller K; Bernreuther C; Lebok P; Clauditz TS; Jacobsen F; Sauter G; Uhlig R; Wilczak W; Steurer S; Minner S; Marx AH; Simon R; Burandt E; Krech T
Exp Mol Pathol; 2022 Jun; 126():104762. PubMed ID: 35390310
[TBL] [Abstract][Full Text] [Related]
6. Cytokeratin 7 and cytokeratin 20 expression in colorectal adenocarcinomas.
Bayrak R; Yenidünya S; Haltas H
Pathol Res Pract; 2011 Mar; 207(3):156-60. PubMed ID: 21282015
[TBL] [Abstract][Full Text] [Related]
7. [Diagnostic value of SATB2, CK7 and CK20 in colorectal cancer].
Lyn J; Wang Y; Wang F; Shen M; Zhou X
Zhonghua Bing Li Xue Za Zhi; 2015 Aug; 44(8):578-81. PubMed ID: 26705182
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological and immunohistochemical study of 20 choroid plexus tumors: their histological diversity and the expression of markers useful for differentiation from metastatic cancer.
Ikota H; Tanaka Y; Yokoo H; Nakazato Y
Brain Tumor Pathol; 2011 Jul; 28(3):215-21. PubMed ID: 21394517
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical expression of CK20, CK7, and CDX2 in colorectal carcinoma in correlation with pathomorphological characteristics.
Ilieva N; Tashkova D; Staykov D; Serteva D; Feodorova Y; Mehterov N; Mollova A; Bachurska S
Folia Med (Plovdiv); 2022 Apr; 64(2):214-220. PubMed ID: 35851772
[TBL] [Abstract][Full Text] [Related]
10. Expression of cytokeratins 7 and 20 in primary carcinomas of the stomach and colorectum and their value in the differential diagnosis of metastatic carcinomas to the ovary.
Park SY; Kim HS; Hong EK; Kim WH
Hum Pathol; 2002 Nov; 33(11):1078-85. PubMed ID: 12454811
[TBL] [Abstract][Full Text] [Related]
11. Identification of relevant prognostic values of cytokeratin 20 and cytokeratin 7 expressions in lung cancer.
Luo HT; Liang CX; Luo RC; Gu WG
Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 28827446
[TBL] [Abstract][Full Text] [Related]
12. Aberrant pattern of the cytokeratin 7/cytokeratin 20 immunophenotype in colorectal adenocarcinomas with BRAF mutations.
Gurzu S; Jung I
Pathol Res Pract; 2012 Mar; 208(3):163-6. PubMed ID: 22361037
[TBL] [Abstract][Full Text] [Related]
13. [Use of thyroid transcription factor-1, surfacfant protein-B, cytokeratin 7 and cytokeratin 20 in discrimination between primary and metastatic adenocarcinoma of lung].
Zou SM; Lin DM; Lü N; Liu XY; Wen P; Liu FS
Zhonghua Yi Xue Za Zhi; 2003 Aug; 83(15):1350-2. PubMed ID: 12930693
[TBL] [Abstract][Full Text] [Related]
14. The value of immunohistochemical expression of TTF-1, CK7 and CK20 in the diagnosis of primary and secondary lung carcinomas.
Al-Zahrani IH
Saudi Med J; 2008 Jul; 29(7):957-61. PubMed ID: 18626520
[TBL] [Abstract][Full Text] [Related]
15. Ovarian mucinous tumors associated with mature cystic teratomas: morphologic and immunohistochemical analysis identifies a subset of potential teratomatous origin that shares features of lower gastrointestinal tract mucinous tumors more commonly encountered as secondary tumors in the ovary.
Vang R; Gown AM; Zhao C; Barry TS; Isacson C; Richardson MS; Ronnett BM
Am J Surg Pathol; 2007 Jun; 31(6):854-69. PubMed ID: 17527072
[TBL] [Abstract][Full Text] [Related]
16. The value of CDX2 and cytokeratins 7 and 20 expression in differentiating colorectal adenocarcinomas from extraintestinal gastrointestinal adenocarcinomas: cytokeratin 7-/20+ phenotype is more specific than CDX2 antibody.
Bayrak R; Haltas H; Yenidunya S
Diagn Pathol; 2012 Jan; 7():9. PubMed ID: 22268990
[TBL] [Abstract][Full Text] [Related]
17. Cytokeratin 7 expression as a predictor of an unfavorable prognosis in colorectal carcinoma.
Hrudka J; Fišerová H; Jelínková K; Matěj R; Waldauf P
Sci Rep; 2021 Sep; 11(1):17863. PubMed ID: 34504224
[TBL] [Abstract][Full Text] [Related]
18. Differential diagnostic and functional role of the multi-marker phenotype CDX2/CK20/CK7 in colorectal cancer stratified by mismatch repair status.
Lugli A; Tzankov A; Zlobec I; Terracciano LM
Mod Pathol; 2008 Nov; 21(11):1403-12. PubMed ID: 18587323
[TBL] [Abstract][Full Text] [Related]
19. Cytokeratin expression profiling in gastric carcinoma: clinicopathologic significance and comparison with tumor-associated molecules.
Takami H; Sentani K; Matsuda M; Oue N; Sakamoto N; Yasui W
Pathobiology; 2012; 79(3):154-61. PubMed ID: 22286119
[TBL] [Abstract][Full Text] [Related]
20. Cytokeratin 7 and 20 expression in cholangiocarcinomas varies along the biliary tract but still differs from that in colorectal carcinoma metastasis.
Rullier A; Le Bail B; Fawaz R; Blanc JF; Saric J; Bioulac-Sage P
Am J Surg Pathol; 2000 Jun; 24(6):870-6. PubMed ID: 10843291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
